دورية
Bendamustine Plus Rituximab Versus Fludarabine Plus Rituximab in Patients with Relapsed Follicular, Indolent, or Mantle Cell Lymphomas – 8-Year Follow-up Results of the Randomized Phase III Study NHL 2-2003 on Behalf of the StiL (Study Group Indolent Lymphomas, Germany)
| العنوان: | Bendamustine Plus Rituximab Versus Fludarabine Plus Rituximab in Patients with Relapsed Follicular, Indolent, or Mantle Cell Lymphomas – 8-Year Follow-up Results of the Randomized Phase III Study NHL 2-2003 on Behalf of the StiL (Study Group Indolent Lymphomas, Germany) |
|---|---|
| المؤلفون: | Rummel, Mathias J., Balser, Christina, Kaiser, Ulrich, Böck, Hans Peter, Stauch, Martina Beate, Heider, Andrea, Welslau, Manfred, Losem, Christoph, Weidmann, Eckhart, Blau, Wolfgang, Burchardt, Alexander, Barth, Jürgen, Kauff, Frank, Hinke, Axel, Brugger, Wolfram |
| المصدر: | Blood; December 2014, Vol. 124 Issue: 21 p145-145, 1p |
| مستخلص: | Off Label Use: Indication and dosage of bendamustine. |
| قاعدة البيانات: | Supplemental Index |
Full Text Finder | تدمد: | 00064971 15280020 |
|---|---|
| DOI: | 10.1182/blood.V124.21.145.145 |